Drug Makers Settle Suit Over Epilepsy Treatment
Kali Laboratories Inc. will not be able to introduce a generic version of a Valeant Pharmaceuticals International epileptic seizure treatment for more than three years under a patent infringement settlement announced...To view the full article, register now.
Already a subscriber? Click here to view full article